Vulnerability · CVE-2020-37284
Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Published Oct 22, 2026 · catalog updated Oct 22, 2026 · Sickbeard
Patch now
CVE-2020-37284 is in the CISA known-exploited catalog. Confirm Sickbeard against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Gaps on this record
- No version range is stored. A customer cannot check an installed version against this record.
- Severity
- Medium5.1
- Known exploitation
- CISA KEV and VulnCheck KEV
- EPSS
- 0.21%
- Remediation
- Remediation guidance
- Affected products
- vendor midgetspy Sickbeard
Sickbeard through build-507 contains a reflected cross-site scripting vulnerability that allows unauthenticated attackers to inject scripts through the pattern parameter of /config/postProcessing/testNaming. Attackers can craft GET requests with malicious SVG onload payloads that the testNaming handler returns unescaped, executing JavaScript in victims' browsers. Exploitation evidence was first observed by the Shadowserver Foundation on 2023-10-22.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor midgetspy Sickbeardversion unspecified
How to fix CVE-2020-37284
Recommended remediation
Apply remediations or mitigations per vendor instructions or discontinue use of the product if remediation or mitigations are unavailable.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2020-37284 is in the CISA known-exploited catalog. Confirm Sickbeard against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Which versions are affected?
Affected version ranges are not on this record. Apply remediations or mitigations per vendor instructions or discontinue use of the product if remediation or mitigations are unavailable.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS). EPSS 0.21%. The CISA KEV listing is the exploitation evidence. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Oct 22, 2026 · CISA KEV
Known exploited
Apply remediations or mitigations per vendor instructions or discontinue use of the product if remediation or mitigations are unavailable.
Oct 22, 2026 · NIST NVD
Detected
Sickbeard through build-507 contains a reflected cross-site scripting vulnerability that allows unauthenticated attackers to inject scripts through the pattern parameter of /config/postProcessing/testNaming. Attackers can craft GET requests with malicious SVG onload payloads that the testNaming handler returns unescaped, executing JavaScript in victims' browsers. Exploitation evidence was first ob
Sources
- CVE.orgVulnerability recordCVE-2020-37284
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2020-37284
30-day exploitation probability 0.21%
first.org - NIST NVDVulnerability recordCVE-2020-37284
Sickbeard through build-507 contains a reflected cross-site scripting vulnerability that allows unauthenticated attackers to inject scripts through the pattern parameter of /config/postProcessing/testNaming. Attackers can craft GET requests with malicious SVG onload payloads that
nvd.nist.gov - VulnCheck KEVConfirmed exploitationCVE-2020-37284
Sickbeard through build-507 contains a reflected cross-site scripting vulnerability that allows unauthenticated attackers to inject scripts through the pattern parameter of /config/postProcessing/testNaming. Attackers can craft GET requests with malicious SVG onload payloads that
vulncheck.com
References
Freshness
Last verified in this catalog Oct 23, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.